Eramol Wins Pharma Contract Services Company of the Year – Small at the 2026 Pharma Industry Awards
Eramol is proud to have been named Pharma Contract Services Company of the Year – Small at the 2026 Pharma Industry Awards UK.
The award was presented at the Gala Ceremony on 23 September 2026 at Park Plaza London Riverbank, bringing together companies and professionals from across the UK pharmaceutical and biotechnology sectors. Eramol was selected as the winner from a strong shortlist that also included Cellomatics Biosciences, Orion GXP Consulting, Paradigm Shift Consulting and PHARMALANE UK. Pharma Awards
For Eramol, the award represents recognition of the continued development of our clinical manufacturing and supply capabilities, as well as the contribution made by teams across the organisation.
A recognition of the whole Eramol team
This achievement reflects the work taking place every day across manufacturing, Quality, QC, Technical, Project Management, Supply Chain, Commercial and supporting functions.
Eramol’s approach has always been built around providing responsive, flexible support for pharmaceutical and biotechnology companies developing clinical-stage products. As the organisation continues to grow, that same focus on quality, communication and practical problem-solving remains central to how we support our clients.
The award also comes at an important stage in Eramol’s development, as we continue to expand our capabilities across sterile and non-sterile clinical manufacturing, packaging and labelling, QC testing, QP release, storage and distribution.
Continued investment in clinical manufacturing
A major focus for Eramol has been the development of our sterile fill-finish capability in Sevenoaks, Kent, designed to support early-phase clinical programmes and high-value drug products.
The facility has been developed with a particular focus on flexible small-batch manufacture, aseptic processing and protecting valuable clinical material during fill-finish. Eramol was also recognised as a finalist in the Innovation of the Year – Small category for its Low-Loss Sterile Manufacturing Platform, further highlighting the importance of yield protection and efficient processing within early-phase drug development. Pharma Awards
For clients working with limited or high-value drug substance, minimising avoidable process losses can have a direct impact on the amount of clinical material available for studies and the overall efficiency of a development programme.
Looking ahead
Winning Pharma Contract Services Company of the Year – Small is an important milestone for Eramol, but it is also recognition of the people behind the organisation.
Every project depends on collaboration between different teams, from initial client discussions and technical assessment through manufacturing, testing, release and final clinical supply.
We would like to thank everyone across Eramol for their continued commitment and contribution, as well as our clients and partners for the trust they place in us.
We look forward to building on this recognition as we continue to expand our capabilities and support more clinical development programmes across the UK, Europe and internationally.
Congratulations to the entire Eramol team.